OnKure Therapeutics, Inc.
OKUR
$2.53
-$0.01-0.39%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | |||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -- | -- | -- | ||
| Cost of Revenue | -- | -- | -- | ||
| Gross Profit | -- | -- | -- | ||
| SG&A Expenses | 285.47% | 220.63% | 2.93% | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 80.47% | 66.12% | 12.33% | ||
| Operating Income | -80.47% | -66.12% | -12.33% | ||
| Income Before Tax | -84.47% | -72.79% | -9.87% | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -84.47% | -72.79% | -9.87% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -84.47% | -72.79% | -9.87% | ||
| EBIT | -80.47% | -66.12% | -12.33% | ||
| EBITDA | -81.37% | -66.74% | -12.28% | ||
| EPS Basic | -92.64% | -71.42% | 31.47% | ||
| Normalized Basic EPS | -82.01% | -71.44% | 31.46% | ||
| EPS Diluted | -92.64% | -71.42% | 31.47% | ||
| Normalized Diluted EPS | -82.01% | -71.44% | 31.46% | ||
| Average Basic Shares Outstanding | -4.23% | 0.79% | 60.34% | ||
| Average Diluted Shares Outstanding | -4.23% | 0.79% | 60.34% | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||